Delivra's current pharmaceutical offerings as per page 7 of their investor slide deck.

Friday, March 20, 2026

Latest

Jeff Bezos Targets $100 Billion Fund to Transform Manufacturing with AI Automation

Recent Qatar LNG Strikes Deepen Global Gas Shock

Why Peru’s 15-Year Mining Concession Plan Is Stirring Alarm

Trans Mountain Targets 1.19 Million Barrels a Day by Decade’s End as Canadian Oil Export Crunch Looms

One Year In, Carney’s Liberals Lead by 11 Points — and Trump Is Now Canada’s Second-Biggest Issue

It’s Not a Crime to Tweet Stupid Things, Musk’s Lawyers Tell Jury

DOJ Responds to Anthropic in Pentagon Lawsuit, Calls Blacklist ‘Lawful and Reasonable’

Iran Attack Slashes 17% of Qatar’s LNG Capacity, Disrupting Global Supply for Up to Five Years

‘We Don’t Trust Her’: Democrats Blow Up Epstein Briefing, Force Bondi Toward Sworn Testimony

Gold Royalty’s Net Loss Persists In Q4 2025 Despite Record Revenue

Delivra’s current pharmaceutical offerings as per page 7 of their investor slide deck.

the deep dive

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations to create quality stock analysis for investors. Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.